-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Paratek Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2017 to Q2 2023.
- Paratek Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $51K.
- Paratek Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2023 was $169K, a 71.8% decline year-over-year.
- Paratek Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $57K, a 90.5% decline from 2021.
- Paratek Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $600K.
- Paratek Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2019 was $301K, a 40% decline from 2018.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)